CT scans are currently the standard for mapping targeted areas for cancer treatment; however, MRI has been shown to produce much better soft tissue definition. This advantage is discussed by David Sebag-Montefiore, MD, of Leeds Teaching Hospitals NHS Trust, Leeds, UK, at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. He highlights how this will improve tumour visualization before, during and after treatment, and thus needs to be widely accepted and accessible UK-wide. Prof. Sebag-Montefiore also discusses the use of MR-LINAC, which brings further benefits but is more costly.
MRI and MR-LINAC guided radiotherapy
